Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Depress Anxiety. 2011 Feb 9;28(5):358–366. doi: 10.1002/da.20793

Table 1.

Means, standard deviations, and reliabilities for pre-treatment study measures for GAD and non-GAD groups by gender.

Measure GAD-group (n = 30)
Non-GAD group (n = 30)
Men Women Men Women



M SD M SD F(1,28) M SD M SD F(1,28) α
VLQ 35.98 14.71 49.87 10.59 8.98** 62.53 15.67 61.33 15.53 .04 .82
QOLI −1.14 1.69 1.44 1.45 20.27*** 2.91 1.14 3.02 1.38 .06 .86
AAQ 45.21 7.02 40.87 6.68 3.01 23.64 6.93 24.31 4.59 .10 .90
ACS 4.19 .66 3.66 .73 4.15* 2.28 .70 2.30 .50 .003 .97
PSWQ 69.28 4.86 63.45 7.03 6.78** 28.21 7.20 35.94 12.08 4.35* .97

Note. VLQ = Valued Living Questionnaire; QOLI = Quality of Life Inventory; AAQ = Acceptance and Action Questionnaire 9-item version; ACS = Affective Control Scale; PSWQ = Penn State Worry Questionnaire. Cronbach’s α reported for the entire sample. F-test represents gender differences within groups.

*

p ≤ .05.

**

p ≤ .01.

***

p ≤ .001.